GENEREX BIOTECHNOLOGY CORP (GNBT)

Company Overview

Generex Biotechnology Corporation engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company’s primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Glucose RapidSpray that delivers glucose through a pump spray to the mouth, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the ...

read more

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 555 Richmond Street West, Suite 604, Toronto, ON M5V 3B1, Canada
Mailing Address: -
Phone: 416-364-2551
Fax: 647-547-7104
Website: http//www.generex.com

Company Details:

Symbol: GNBT
SIC: -
State location: A1
Sector: -
State of Inc: DE
Employees: 43
Type: -

Key executives:

Name Age Position
Anna E. Gluskin 65 Chairman, Chief Exec. Officer and Pres
Eric Von Hofe Ph.D. 2016 Pres of Antigen Express
Gerald Bernstein M.D. 83 VP of Medical Affairs
Mark Fletcher Esq. 50 Exec. VP and Gen. Counsel
Rose C. Perri 49 Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer